General Clinical Pharmacology Considerations for Neonatal Studies for Drugs and Biological Products Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 27, 2022
April 15, 2024
0c57731e-55bc-4962-a619-54444aa22335
Related Documents
E8(R1) General Considerations for Clinical Studies
Guidance DocumentApril 8, 2022Center for Drug Evaluation and Research
Clinical Pharmacology Considerations for Antibody-Drug Conjugates Guidance for Industry: Guidance for Industry
Guidance DocumentMarch 1, 2024Center for Drug Evaluation and Research
Rare Diseases: Considerations for the Development of Drugs and Biological Products
Guidance DocumentDecember 26, 2023Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.